TACE and tyrosine kinase inhibitors with or without PD-1 inhibitors as first-line therapy for intermediate-advanced HCC: a multicenter real-world cohort study

  1. Xue-Gang Yang
  2. Li-Wei Deng
  3. Yong Zhao
  4. Bo Peng
  5. Bin Liu
  6. Shi-Feng Feng
  7. Dong-Xu Liu
  8. Jun-Feng Liu
  9. Yan-Yuan Sun
  10. Yan Chen
  11. Chang-Li Liao
  12. Chi Zhang
  13. Le Liu
  14. Lei Cao
  15. Yi Ren
  16. Guo Wei
  17. Guo-Hui Xu
Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1007/s12072-026-11052-0
  2. Version published to 10.21203/rs.3.rs-8029505/v1 on Research Square